CLINICAL_TRIALS
trial_result
· 2026-04-29
Clinical Trial Update: Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) [Phase 3]
Summary
Phase 3 trial update on seralutinib in adults with pulmonary arterial hypertension reports efficacy and safety results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GB002, Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED